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In our research performed using model of acoustic trauma at experimental animals (female 
of hybrids F1 of CBA and C57BL/6  lines) influence of triazin-indole at expression level of 
hypoxia induced factor (HIF) in Corti’s organ was studied at its therapy application. As a refer-
ence drug cytoflavin was used. Investigated drug in the form of 1 % solution was introduced 
into animals parenterally in dosage 5, 7, 10 mg/kg with 2 hr intervals after acoustic impact. 
Injection of cytoflavin as reference drag was performed in 1.7  ml/kg dosage. Level of HIF 
expression in the drug of Corti’s organ was estimated using immunohistochemical method. 
It was found out that triazin-indole derivative increases HIF expression in Corti’s cells and in 
neurons of spiral ganglion at acoustical traumatic impact depending on drug dosage increase. 
Maximal HIF expression in Corti’s cells and in ganglions were noted at therapeutic dose of the 
drug 10 mg/kg. In control group and in the group with application citoflavin in dose 1.7 ml/kg 
minimal HIF expression was observed. According to obtained results of performed investiga-
tion the authors concluded that antisurdant property of triazin-indole derivative is realized 
through the influence on HIF metabolism (probably, by blockage of prolyl hydroxylase) and 
enables to consider it as a target molecular during the drug application.
Keywords: hypoxia, induced fator, HIF-1, acoustical trauma, antihypoxic drugs, triasin-indole, 
expression, laboratory animals, mean cytochemical coefficient.
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Actuality 
According to data on 2019, among professional diseases in Russian Federation, caused 
by noise impact, sensorineural hearing loss is prevailed: its part in total diseases amount 
in the group constitutes 54.38 % [1]. According to WHO data, to 2050 over 900 million 
persons will suffer from incapacitating loss of hearing. 1.1 billion young people (at age 
12–35 years) are subjected to the risk of hearing loss as a result of noise impact. One-third 
of all cases hearing loss are associated with noise [2]. Acoustical traumatic organ of hear-
ing damage by high intensity noises are noted in different industries [3; 4], but most of all 
typical for military work [5; 6]. 
One of the main pathogenetic links at acoustic trauma is internal ear microcircu-
lation disorder [7]. It is associated in the first place with peculiarities its blood supply 
and anatomical organization [8]. Vascular stria edema leads to cochlear hypoxia, oxida-
tive stress and, finally, to Corti cells death due to necrosis or apoptosis pathways activa- 
tion [9]. 
In the modern literature great attention is paid to hypoxia-induced factor (HIF), for 
discovery and study of which Gregg L. Semenza, Peter J. Ratcliff and William Bill George 
Kaelin awarded Nobel Prize in physiology and medicine in 2019 [10; 11]. HIF molecule 
presents itself a heterodimer, consisting of oxygen-depending transcriptionally active sub-
units HIF-1α and HIF-2α and oxygen-independent subunit HIF-1β [10]. There also exists 
isoform HIF-3α, capable to inhibit HIF-1/2α action [12]. In normal oxygen conditions 
HIF-1α molecule hydroxylates with prolyl hydroxylase (PHD) ferment participation, in-
teracts with protein Von Hippel–Lindau (pVHL), being ubiquitinylated and subjected to 
proteasomal degradation [13]. Molecular oxygen take part in reaction of hydroxylation, as 
well as ions of iron and ascorbic acid and in case of insufficiency of one of the components 
this reaction becomes impossible, leading to increase of HIF-1α number [14]. In case of 
oxygen insufficiency, two subunits HIF-1α and HIF-1β penetrate into cell nucleus and 
regulate expression of hundreds target genes, participated in angiogenesis, erythrogenesis, 
carbohydrate metabolism, cellular proliferation and etc. [15; 16].
J. H. Pak in his work showed, that in conditions of preconditioning using cobaltous 
chloride, elevated HIF-1α expression take place and protecting action of Corti’s organ is 
implemented in case of noise impact [17].
Actual is a search of medicines and healthcare products, directed on struggle with 
hypoxic hearing organ damage in case of acoustical traumatic impact, including impact 
on HIF molecule. 
Purpose 
To study the level of hypoxia-induced factor HIF-1α in Cortia’s cells using the model 
of acoustic trauma at application triasin-indole derivative.
Experimental animals and methods 
Experiments were carried out on 65  mice, females of F1  hybrids CBA and 
C57BL/6 lines with weight at least 17 g and 4–12 weeks age, delivered from mous bank of 
Russian Medical science Academy “Rappolovo” (Leningrad region, Russia). Experiments 
were carried out after 14 day of animals adaptation in vivarium. All the researches were 
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performed in accordance with requirements of European Convention for the Protection 
of Vertebrate Animals used for Experimental and Other Scientific Purposes (Strasbourg, 
1996), good laboratory practice (Order of Ministry of Labor and Social Protection, Rus-
sian Federation, dated 23.08.2010), guidelines on preclinical studies. Mice euthanasia was 
performed by means of ethal dose of anesthesia, used in experiments — intra-abdominal 
injections of Telazol (50–70 mg/kg). 
New derivative of triazin-indole (Trisan) 3-[(2-morfolinoetiltio]  — 5Н  — 1,2,4- 
triazino [5,6-b] indole hydrochloride, monohydrate, for the first time synthesized by doc-
tor of science, professor L. V. Pastushenkov at pharmacological department of Military 
Medical Academy named after S. М. Kirov. As a reference drug citoflavin was used, that 
provide antioxidative, antihypoxic action which is used in ENT practice for treating acute 
and chronic bradyacusia [18]. 
At modeling acute acoustical trauma after initial registration auditory evoked poten-
tials, animals during 3-hour white noise impact at level 107 dB in ultrasonic range and 
bandwidth from 3 to 100000 Hz (noise generator GRC Concord 1390-В, USA). Noise lev-
el 107 dB corresponded to the level, measured by Brüel & Kjr system (Denmark): 6.5 mm 
gauge microphone of 4135 type, preamplifier 2633 and measuring amplifier 2606 in the 
point of tympanic membrane location of investigated ear. Auditory evoked potential reg-
istration was performed directly after acoustic impair impact, and also after 1 and 2 hours 
after acoustic trauma.
1 % solution of investigated drug Trisan was injected into animals intravenously, in-
tramuscularly and abdominally using single-use syringes. For convenience of injecting re-
sulting 1 % Trisan solution was diluted using physiological solution NaCl (1 ml 1 % Trisan 
solution and 9 ml 0.9 % NaCl solution). With therapeutic purpose, the drug was injected 
in 5, 7, 10 mg/kg dosage in 2 hours after acoustic impact. In the same manner dilution 
and injection of reference drug, citoflavine, was performed in 1.7 ml/kg dosage. In control 
group experimental animals physiological solution was injected. 
After the experiment, Corti’s organ was extracted as a part of excised temporal bone 
and then was fixed using 10 % normal (pH 7,4) formaldehyde solution for 12 hours. Ob-
tained fixed samples were subjected to decalcination by means of incubation in solution 
for rapid decalcination (Bio-Vitrum, Russia) for 30 minutes. Histological specimens pro-
cessing and imbibition samples by paraffin was performed using automated tissue pro-
cessor Exelsior ES (Thermo, Great Britain). Paraffin section 5  micrometers thick were 
obtained by means of semi-automated rotary microtome with system of slice transfer 
HM350 (Thermo, Great Britain). 
Immunohistochemical investigations were carried out with application peroxidase-
labeled rabbit monoclonal primary antibodies (Immunotech, Russia). Estimate of col-
oring was carried out by mean cytochemical coefficient (MCC), developed by the au-
thors. Numbers from 1 to 6 were used to denote intensity of coloring at HIF-1α expres- 
sion.
Results
While analyzing obtained materials it was noted: absence of HIF-1  expression by 
neuroreceptor system cells; low HIF expression by cells in spiral ganglion in case of con-
trol group and in the group where citoflavine was used (Fig. 1). 
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At therapeutic dose 5 mg/kg of the drug low HIF-1 expression by neuroreceptor sys-
tem cells, moderate HIF-1 expression by spiral ganglion cells. In case of drug injection at 
7 mg/kg dose moderate HIF-1 expression by neuroreceptor system cells and by spiral gan-
glion cells as well. Noticeable HIF-1 expression was observed in case of application Trisan 
dose 10 mg/mg, injected in 2 hours after acoustic traumatic impact (Fig. 2). 
Fig. 1. Absence of HIF-1 expression by neuroreceptor system cells; low HIF ex-
pression by spiral ganglion cells (control group — to the left; citoflavine — to the right)
Fig. 2. HIF-1 expression by neuro-
receptor system cells and by spiral gan-
glion cells (therapeutic dose 10 mg/kg)
Fig.  3. Level of HIF-1  expression dependence (using mean cito-
chemical indication) (abscissa axis) on injected therapeutic dosage of 
triasin-indole (ordinate axis)
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With the help of obtained results it was found out that increase of HIF-1 expression 
in Corti’s cells and in neurons of spiral ganglion at application of triasin-indole derivative 
depends on the dose used and coincide with electrophysiological changes in experimental 
animals (Fig. 3). 
This regularity enables to suppose, that molecule target for the drug is HIF. Maximal 
HIF expression in Corti’s cells and in ganglions were noted at therapeutic dose of the drug 
10 mg/kg.
Discussion 
Increase of HIF expression level at application of medicinal drugs according to li- 
terature data are due to ferment PHD suppression, which participated in HIF molecule 
hydroxylation, that lead to its proteoclastical degradation [19–22]. Deferoxamine and di-
methyloxalylglycine inactivate PHD, forming complex with iron, which is its cofactor [23; 
24]. Cobaltous chloride increases accumulation and transcriptional activity of HIF due to 
iron and ascorbic acid exclusion from its metabolism [26].
In the recent works it was shown that HIF stability is reached due to application 
micro-RNA and VP16-HIF-1α viruses by means of modern genetic engineering methods 
[27; 28].
According to the data, obtained in course of our work performance, triasin-indole 
derivative possesses antisurdant property due to the influence on HIF expression level. 
Most probably, due to ferments blockage participated in its degradation (prolyl hydroxy-
lase). It enables to consider that complex as perspective pathogenetic drug for prevention 
and treating bradyacusia of noise etiology.
Conclusions 
Based on the results of our investigation and literature analysis, we concluded that 
triasin-indole derivative possesses possesses antisurdant property due to the influence on 
HIF expression level as molecule target for the drug. With increase of triasan dose regular 
increase of HIF-1 expression in Corti’s cells and in ganglions were noted, that coincided 
with elctrophysiological changes in experimental animals. We suppose that mechanism of 
the drug action is associated with ferments blockage which participated in its proteosomal 
degradation (prolyl hydroxylase). 
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